Muscles on-a-chip provide insight into cardiac stem cell therapies

Stem cell-derived heart muscle cells may fail to effectively replace damaged cardiac tissue because they don't contract strongly enough, according to a study in The Journal of Cell Biology. The study, "Coupling Primary and Stem Cell-Derived Cardiomyocytes in an In Vitro Model of Cardiac Cell Therapy," by Yvonne Aratyn-Schaus and Francesco Pasqualini and colleagues, may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.

The possibility of using stem cells to replace damaged tissue following a heart attack has interested researchers for many years. Though transplanted into patients can develop into (cardiomyocytes) and integrate with undamaged regions of , several pre-clinical studies and clinical trials have failed to identify significant improvements in the contractile function of the heart.

One explanation for this could be that mechanical forces are not transmitted properly between the new, stem cell-derived cardiomyocytes and the old, surviving heart cells. The mechanical forces exchanged by cardiomyocytes are impossible to measure in patients. So, a team of researchers led by Professor Kit Parker at Harvard University developed a simplified, in vitro system in which single heart cells isolated from mice are combined with individual, stem cell-derived cardiomyocytes to form a two-cell "microtissue" that the researchers call a "muscle on-a-chip."

Using this approach, Pasqualini and Aratyn-Schaus, post-doctoral fellows in the Parker lab and co-first authors of the study, found that stem cell-derived cardiomyocytes could structurally couple, and synchronously beat with mouse cardiomyocytes. Stem cell-derived myocytes contracted less strongly than their partners, however, and this imbalance resulted in the cells transmitting to their surroundings, instead of to each other.

A two-cell "microtissue" contains a mouse embryonic stem cell-derived cardiomyocyte and a mouse neonatal cardiomyocyte. The lower panel shows the traction forces generated as the two cells contract; the stronger, neonatal cardiomyocyte produces more force than the weaker, stem cell-derived cardiomyocyte. Credit: Aratyn-Schause, Y. et al. J Cell Biol. 2016

Computer simulations revealed that the unequal forces generated by stem cell-derived and native cardiomyocytes are sufficient to induce the formation of cellular adhesions that can dissipate force to the cells' surroundings. The computer model also suggests that human cardiomyocytes are likely to behave similarly.

Inefficient force transmission may therefore explain why stem cell transplantation has been somewhat ineffective in restoring normal heart function. Parker and colleagues' muscle on-a-chip technique should help researchers develop ways to improve the mechanical coupling of stem cell-derived cardiomyocytes to surviving heart tissue.


Explore further

Cardiac muscle cells as good as progenitors for heart repair

More information: Aratyn-Schaus, Y., et al. 2016. J Cell Biol. dx.doi.org/10.1083/jcb.201508026
Journal information: Journal of Cell Biology

Citation: Muscles on-a-chip provide insight into cardiac stem cell therapies (2016, February 8) retrieved 23 September 2019 from https://medicalxpress.com/news/2016-02-muscles-on-a-chip-insight-cardiac-stem.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more